StockData

Universe Pharmaceuticals INC (UPC) stock

UPCNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jan 29, 2026Score 5/30
$1.52−0.04 (-2.48%)

Close on Nov 18, 2026Market cap $857.01KP/E –Yield –

Universe Pharmaceuticals net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -$3.67B. The highest annual figure on record is $11.32M in fiscal 2021.

Annual net income

PeriodPeriod endValueChange
FY2025Sep 30, 2025-$3.67B–
FY2024Sep 30, 2024-$8.73B–
FY2023Sep 30, 2023-$6.58B–
FY2022Sep 30, 2022-$7.91M-169.9%
FY2021Sep 30, 2021$11.32M+49.8%
FY2020Sep 30, 2020$7.56M–

More Universe Pharmaceuticals figures

See a number that looks wrong?